| Literature DB >> 36064772 |
Connor Wiegand1, Wen Liu2, Catherine McCormick3, Ann Zeleniak2, Ravikumar K1, Amir Alavi4, Haonan Guan3, Suzanne Bertera2, Robert Lakomy2, Asako Tajima2, Henry Cohen2, Stephanie Wong2, Lame Balikani5, Benjamin Mizerak1, Ziv Bar-Joseph4, Massimo Trucco2,3,6, Ipsita Banerjee1, Yong Fan7,8,9,10.
Abstract
Hematopoietic humanized (hu) mice are powerful tools for modeling the action of human immune system and are widely used for preclinical studies and drug discovery. However, generating a functional human T cell compartment in hu mice remains challenging, primarily due to the species-related differences between human and mouse thymus. While engrafting human fetal thymic tissues can support robust T cell development in hu mice, tissue scarcity and ethical concerns limit their wide use. Here, we describe the tissue engineering of human thymus organoids from inducible pluripotent stem cells (iPSC-thymus) that can support the de novo generation of a diverse population of functional human T cells. T cells of iPSC-thymus-engrafted hu mice could mediate both cellular and humoral immune responses, including mounting robust proinflammatory responses on T cell receptor engagement, inhibiting allogeneic tumor graft growth and facilitating efficient Ig class switching. Our findings indicate that hu mice engrafted with iPSC-thymus can serve as a new animal model to study human T cell-mediated immunity and accelerate the translation of findings from animal studies into the clinic.Entities:
Mesh:
Year: 2022 PMID: 36064772 DOI: 10.1038/s41592-022-01583-3
Source DB: PubMed Journal: Nat Methods ISSN: 1548-7091 Impact factor: 47.990